SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-040087
Filing Date
2022-12-30
Accepted
2022-12-30 17:00:51
Documents
12
Period of Report
2022-12-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20221230.htm   iXBRL 8-K 40038
  Complete submission text file 0001564590-22-040087.txt   168845

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tcon-20221230.xsd EX-101.SCH 5605
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20221230_lab.xml EX-101.LAB 19329
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20221230_pre.xml EX-101.PRE 11498
6 EXTRACTED XBRL INSTANCE DOCUMENT tcon-8k_20221230_htm.xml XML 3564
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 221502502
SIC: 2836 Biological Products, (No Diagnostic Substances)